Compare MCK & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCK | ELV |
|---|---|---|
| Founded | 1833 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.0B | 85.7B |
| IPO Year | 1995 | 2001 |
| Metric | MCK | ELV |
|---|---|---|
| Price | $750.64 | $388.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 19 |
| Target Price | ★ $952.92 | $383.56 |
| AVG Volume (30 Days) | 874.4K | ★ 1.4M |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | 0.40% | ★ 1.83% |
| EPS Growth | ★ 49.22 | N/A |
| EPS | ★ 38.38 | 8.00 |
| Revenue | $112,084,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $14.94 | N/A |
| Revenue Next Year | $8.21 | $3.07 |
| P/E Ratio | ★ $19.56 | $48.56 |
| Revenue Growth | 3.11 | ★ 12.49 |
| 52 Week Low | $637.00 | $273.71 |
| 52 Week High | $999.00 | $426.98 |
| Indicator | MCK | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 47.26 |
| Support Level | $727.64 | $384.30 |
| Resistance Level | $779.31 | $408.00 |
| Average True Range (ATR) | 16.90 | 11.27 |
| MACD | 2.89 | -3.82 |
| Stochastic Oscillator | 30.13 | 3.56 |
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.